ZyVersa Therapeutics, Inc.
Navigate ZyVersa Therapeutics, Inc.
Home
About
About
Our Vision/Mission
Management Team
CEOCFO Magazine Interview With CEO
Board of Directors
Scientific Advisory Board: Inflammatory Diseases
Scientific Advisory Board: Renal Disease
Inflammasomes
Inflammasomes
IC 100: ASC Inhibitor
IC 100: MOA Video
IC 100 Infographic, Mechanism of Action
ASC Biomarker
Inflammasome Publications
White Paper: Inflammasomes, a Promising Therapeutic and Diagnostic Target
Renal Lipids
Renal Lipids
White Paper: Renal Lipids in the Pathogenesis of Kidney Disease
VAR 200, Cholesterol Efflux Mediator, 2HPβCD
Cyclodextrin Publications
Renal Disease Publications
Pipeline
Pipeline
Collaboration
About FSGS
About Alport Syndrome
About Diabetic Kidney Disease
About Multiple Sclerosis
Careers
News Center
Corporate News Releases
Corporate Presentations
Media Resources
Corporate Media Contact
ZyVersa Featured Article, Business Worldwide Magazine
Contact
Home
News Center
Corporate News Releases
Corporate News Releases
Oct 4, 2021 • 7:08 AM EDT
ZyVersa Therapeutics' CCO, Karen A. Cashmere, Invited Speaker at Inflammasome Therapeutics Summit 2021
Sep 9, 2021 • 7:08 AM EDT
ZyVersa Therapeutics' CEO, Stephen C. Glover Invited Panel Member at Inflammasome Therapeutics Summit 2021
Sep 7, 2021 • 7:08 AM EDT
ZyVersa Therapeutics' CEO, Stephen C. Glover Invited Speaker at the H.C. Wainwright 23rd Annual Global Investment Conference, September 13-15, 2021
Aug 3, 2021 • 7:08 AM EDT
ZyVersa Therapeutics' CEO, Stephen C. Glover to Present at BTIG's Virtual Biotechnology Conference 2021
Jul 15, 2021 • 7:08 AM EDT
ZyVersa Therapeutics' CEO, Stephen C. Glover to Present at 2nd Annual LifeSci Partners' Virtual Private Company Summer Symposium July 21-23, 2021
Mar 3, 2021 • 12:55 PM EST
ZyVersa Therapeutics' CEO, Stephen C. Glover to Present at the H.C. Wainwright Global Life Sciences Conference Being Held Virtually March 9-10, 2021
Feb 26, 2021 • 7:05 AM EST
ZyVersa Therapeutics' CSO, Nicholas A. LaBella, Jr., to Present at the 3rd Annual Chronic Kidney Disease Drug Development Summit Being Held Virtually March 2-4, 2021
Jan 6, 2021 • 12:55 PM EST
ZyVersa Therapeutics' CEO, Stephen C. Glover to Participate in the 39th Annual J.P. Morgan Healthcare Conference 2021, January 11th - 14th
Nov 16, 2020 • 7:08 AM EST
ZyVersa Therapeutics' CEO, Stephen C. Glover to Present at the Stifel 2020 Virtual Healthcare Conference on November 18, 2020
Oct 12, 2020 • 7:08 AM EDT
Review Article, Authored by ZyVersa Therapeutics' Esteemed Scientific Advisors, Demonstrates the Role of Inflammasomes in the Exacerbated Immune Response Associated with COVID-19 Infection (Just Published in Frontiers in Immunology)